InvestorsHub Logo
Followers 163
Posts 12880
Boards Moderated 1
Alias Born 01/26/2016

Re: iwasadiver post# 62519

Saturday, 05/21/2016 1:58:16 PM

Saturday, May 21, 2016 1:58:16 PM

Post# of 699499
iwasadiver,

The key to regulating checkpoint pathways may all boil down to one very conserved and inescapable signaling molecular relationship which I believe NWBO understands very well. This is the reason their checkpoint combination patent will stand up over time and is a thorn in the side of big pharma and their investor advocates alike. Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News